Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,504 | -16,686 | -8,273 | -28,672 | -17,992 |
| Depreciation Amortization | 1,164 | 777 | 392 | 1,616 | 1,227 |
| Accounts receivable | -2,284 | -1,125 | -144 | 217 | 193 |
| Other Working Capital | -5,521 | -3,530 | -1,840 | -3,402 | -5,792 |
| Other Operating Activity | 4,080 | 2,380 | 703 | 246 | -273 |
| Operating Cash Flow | $-26,065 | $-18,184 | $-9,162 | $-29,995 | $-22,637 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 0 | 0 | 3,975 | 2,981 |
| PPE Investments | -349 | -296 | -175 | 2,612 | 2,738 |
| Purchase Of Investment | N/A | N/A | N/A | -300 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -305 | -305 |
| Investing Cash Flow | $-349 | $-296 | $-175 | $5,982 | $5,414 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -346 | N/A | N/A | N/A |
| Debt Repayment | -513 | N/A | -173 | -1,200 | -1,022 |
| Common Stock Issued | 29,699 | 12,689 | 6,055 | 23,375 | 28,881 |
| Common Stock Repurchased | N/A | N/A | N/A | 6,000 | N/A |
| Other Financing Activity | -850 | 0 | 0 | -1,599 | -1,599 |
| Financing Cash Flow | $28,336 | $12,343 | $5,882 | $26,576 | $26,260 |
| Beginning Cash Position | 11,465 | 11,465 | 11,465 | 8,902 | 8,902 |
| End Cash Position | 13,387 | 5,328 | 8,010 | 11,465 | 17,939 |
| Net Cash Flow | $1,922 | $-6,137 | $-3,455 | $2,563 | $9,037 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,065 | -18,184 | -9,162 | -29,995 | -22,637 |
| Capital Expenditure | -349 | -296 | -175 | -563 | -437 |
| Free Cash Flow | -26,414 | -18,480 | -9,337 | -30,558 | -23,074 |